EN
HI
Ajanta Pharma Share price
AJANTPHARM
3697.9
8.50 (-0.23%)NSE
BSE
Last updated on 19 Aug, 2026 | 15:59 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Ajanta Pharma share price chart
Ajanta Pharma Share Key Metrics
Volume
84540.00
Market Cap
46199.94 CR
LTQ@LTP
2@3697.90
ATP
3719.49
Var Margin
14.94 %
Circuit Range
2965.2-4447.6
Delivery %
50.33 %
Value
31.44 CR
ASM/GSM
No
Market Lot
1
Summary
AJANTPHARM stock price is ₹3697.9 as of 20 Aug, 2026. The stock intraday movement has stayed between ₹3668.00 and ₹3782.70, while Ajanta Pharma share price 52 week high low is ₹2329.90 & ₹3796.00.
In terms of trading activity, AJANTPHARM share price has recorded a volume of 84,540 shares. The Ajanta Pharma has a market cap of ₹124935624. The stock’s Average Traded Price (ATP) stands at ₹3719.49, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2 @ ₹3697.90.
The Ajanta Pharma upper circuit limit is ₹4447.60 & The Ajanta Pharma lower circuit limit is ₹2965.20, with a Value of ₹31.44 CR. The Delivery Percentage for the day is 50.33%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Ajanta Pharma Resistance and Support
Pivot 3732.13
Resistance
First Resistance
3770.26
Second Resistance
3834.13
Third Resistance
3872.26
Support
First Support
3668.26
Second Support
3630.13
Third Support
3566.26
Ajanta Pharma Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
63.48%
Mutual Fund
18.1%
Insurance
3.29%
Foreign Institutional Investors
7.68%
Domestic Institutional Investors
0.41%
Retail
7.03%
Others
0.01%
Total Promoters
MAR '26
66.25%
JUN '26
63.48%
Ajanta Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-30 | Quarterly Results & Interim Dividend |
| 2026-05-05 | Audited Results |
| 2026-01-30 | Quarterly Results |
| 2025-11-03 | Quarterly Results & Interim Dividend |
| 2025-07-28 | Quarterly Results & Others |
| 2025-04-30 | Audited Results & A.G.M. |
| 2025-01-30 | Quarterly Results |
| 2024-10-28 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-08-05 | 2026-08-05 | View More |
Ajanta Pharma News
Ajanta Pharma Ltd - 532331 - Participation In Investor Conference
Ajanta Pharma has released its schedule for upcoming analyst and institutional investor meetings in August 2026. These meetings, including participation in Nuvama India Conference and Motilal Annual Global Conference, will discuss already published information.
Aug 05 2026 16:55:00
Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Ajanta Pharma has uploaded the audio recording of its earnings call for Q1 FY27, conducted on July 30, 2026, to its official website. This provides investors access to the discussion about the company's recent financial performance.
Jul 30 2026 17:38:42
Ajanta Pharma Ltd - 532331 - Record Date Intimation For Dividend
Ajanta Pharma fixed August 5, 2026, as the Record Date. This date is for determining shareholders eligible for the 1st interim dividend.
Jul 30 2026 14:43:56
Ajanta Pharma Ltd - 532331 - Corporate Action-Board approves Dividend
Ajanta Pharma declared a ₹32 interim dividend per share (face value ₹2) for FY27, with a total payout of ₹400 crores. The record date is August 5, 2026, and payment will be on or after August 18, 2026.
Jul 30 2026 14:42:33
Ajanta Pharma Ltd - 532331 - Board Meeting Outcome for BM Outcome
Ajanta Pharma reported robust Q1 FY27 consolidated financial results with revenue up 25% to ₹1,626 cr and net profit rising 31% to ₹334 cr. The board also approved a ₹32 interim dividend per share for FY27.
Jul 30 2026 14:35:43
Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Ajanta Pharma promoter Aayush Agrawal re-pledged 21.61 lakh shares (1.73% of total share capital) on July 24, 2026. This action serves as security for the issuance of new non-convertible debentures, with no net change in pledged holding.
Jul 29 2026 12:23:10
Read More
Ajanta Pharma Management
| Name | Position |
|---|---|
| Gaurang Shah | Sr. VP – Legal, Company Secretary & Compliance Officer |
| Mannalal B Agrawal | Chairman |
Ajanta Pharma Similar Stocks
Alkem Laboratories Ltd.
5382.50
-92.50 (1.69%)
Abbott India Ltd.
26405.00
-175.00 (0.66%)
Anthem Biosciences Ltd.
881.90
-9.15 (1.03%)
Gland Pharma Ltd.
2841.30
-17.30 (0.61%)
Ipca Laboratories Ltd.
1903.70
21.60 (1.15%)
Glaxosmithkline Pharmaceuticals Ltd.
3032.40
155.00 (5.39%)
Global Health Ltd.
1417.20
-25.50 (1.77%)
Narayana Hrudayalaya Ltd.
1785.70
-17.30 (0.96%)
Emcure Pharmaceuticals Ltd.
1891.00
16.50 (0.88%)
Ajanta Pharma FAQs
The Buying Price of Ajanta Pharma share is 3697.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Ajanta Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ajanta Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Ajanta Pharma shares is 40.76. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Ajanta Pharma shares is 9.52. Useful to assess the stock's value relative to its book value.
To assess Ajanta Pharma’s valuation compare Sector P/E, P/B which are 64.9 & 3.32 with sector averages, along with growth rates and financial metrics.
The Market Cap of Ajanta Pharma is 46199.94 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Ajanta Pharma share price is 3796.00 & 2329.90. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Ajanta Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in AJANTPHARM
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in AJANTPHARM
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade